[Granulomatous lung disease induced by kayexalate inhalation during immunotherapy for metastatic melanoma].

Samaran Q, Girard C, Lerisson M, Boissin C, Jossien A, Serre I, Guillot B

Open source

DOI
10.1016/j.rmr.2021.04.016
Published
2021 Jun
Container
Revue des maladies respiratoires
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.rmr.2021.04.016,
  title = {[Granulomatous lung disease induced by kayexalate inhalation during immunotherapy for metastatic melanoma].},
  author = {Samaran Q and Girard C and Lerisson M and Boissin C and Jossien A and Serre I and Guillot B},
  year = {2021},
  journal = {Revue des maladies respiratoires},
  doi = {10.1016/j.rmr.2021.04.016},
  url = {https://doi.org/10.1016/j.rmr.2021.04.016}
}

RIS

TY  - JOUR
TI  - [Granulomatous lung disease induced by kayexalate inhalation during immunotherapy for metastatic melanoma].
AU  - Samaran Q
AU  - Girard C
AU  - Lerisson M
AU  - Boissin C
AU  - Jossien A
AU  - Serre I
AU  - Guillot B
PY  - 2021
JO  - Revue des maladies respiratoires
DO  - 10.1016/j.rmr.2021.04.016
UR  - https://doi.org/10.1016/j.rmr.2021.04.016
ER  - 

APA

Q, S., C, G., M, L., C, B., A, J., I, S., & B, G. (2021). [Granulomatous lung disease induced by kayexalate inhalation during immunotherapy for metastatic melanoma].. Revue des maladies respiratoires. https://doi.org/10.1016/j.rmr.2021.04.016

Source records